Klein Lawrence Otto
Reporting owner on Forms 3, 4 and 5, CIK 1762583.
Klein Lawrence Otto reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Oruka Therapeutics, Inc. CIK 907654 | director, officer (Chief Executive Officer) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. Common Stock | 2026-10-01 | M exercised | +25,000 | $7.8 | 948,128 | Form 4 |
| Oruka Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -16,246 | $83.3979 | 931,882 | Form 4 |
| Oruka Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -8,554 | $84.0256 | 923,328 | Form 4 |
| Oruka Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -200 | $84.78 | 923,128 | Form 4 |
| Oruka Therapeutics, Inc. Employee Warrant (right to buy), derivative | 2026-10-01 | M exercised | -25,000 | $0 | 1,528,513 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0000907654-26-000104 | Oruka Therapeutics, Inc. | 2026-10-02 |